|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Progestin-only hormonal contraception. |
| ARHP CLINICAL PROCEEDINGS. 1997 Aug;:18-20. |
| Progestin-only hormonal contraception increases the reproductive choices available to women in whom exogenous |
| estrogens are contraindicated. Currently available methods include progestin-only pills, parenteral depot |
| medroxyprogesterone acetate, progestin-containing IUDs, and levonorgestrel-releasing implants. Unlike combined |
| hormonal contraceptives, progestin-only methods are appropriate for women with estrogen-dependent neoplasia, |
| cholastaic jaundice, thromboembolic disease, chronic liver disease, connective tissue disease, and migraine |
| headaches. Although initial unpredictable menstrual bleeding is a common side effect of progestin-only methods, |
| its occurrence tends to diminish over time. These contraceptive agents also offer many noncontraceptive benefits, |
| including protection against endometrial and ovarian cancer, reduction of pelvic inflammatory disease risk, promotion |
| of breast milk production, and treatment of ovulation disturbances. (PubHealth.info Document ID: CONT2T 1010-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Progestin-only hormonal contraception.", is(are) . The |
| source of this article is "ARHP CLINICAL PROCEEDINGS. 1997 Aug;:18-20.". This article was published in 1997 in |
| English language(s). (PubHealth.info® Document ID: CONT2T 1010-06. All rights reserved with PubHealth.info) PIN: |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |